Novo Looking To Position Liraglutide As First Once-Daily Injection Following Oral Drug Failures

Novo Nordisk reports positive top-line data from the first of five Phase III studies evaluating the GLP-1 analog.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet